Suppr超能文献

一种乙酰胆碱酯酶抑制剂(多奈哌齐)对韦尼克-科尔萨科夫综合征记忆的治疗作用。

Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff's disease.

作者信息

Sahin Hüseyin A, Gurvit I Hakan, Bilgiç Başar, Hanagasi Hasmet A, Emre Murat

机构信息

University of Istanbul, Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Turkey.

出版信息

Clin Neuropharmacol. 2002 Jan-Feb;25(1):16-20. doi: 10.1097/00002826-200201000-00003.

Abstract

Wernicke-Korsakoff's disease (WKD) is cognitively an amnestic state resulting from strategic lesions in the limbic system subserving the episodic memory network and resulting from thiamine deficiency. Neurochemical deficits have been implicated in the pathophysiology of amnesia based on the pathologic observations that various brainstem and basal forebrain nuclei are also affected. Previous treatment attempts with serotoninergic, noradrenergic, and cholinergic drugs have given controversial results. The objective of this study was to assess the effects of a cholinesterase inhibitor, donepezil, on memory, attention, and executive functions in patients with nonalcoholic WKD. Seven patients who developed WKD after a hunger strike were included in this single, blind, placebo-controlled, one-way, crossover study. The patients were administered donepezil during the first 30 days, and were administered placebo during the following 30 days. Neuropsychological tests to evaluate verbal and visual memory, and attention and executive function were performed on days 0, 31, and 61. All patients completed both phases of the study. There were no statistically significant differences between the three evaluations, except for a difference between active treatment and the placebo phase during recall of the Rey-Osterrieth complex figure, which was in favor of the placebo phase. There were no significant changes in favor of the active treatment. Cholinergic treatment with the cholinesterase inhibitor donepezil does not seem to provide marked beneficial effects in patients with WKD in this small, descriptive study. This may be because pathways mediating channel and state-dependent functions are impaired in this disease, and enhancement of state-dependent cholinergic transmission may not be sufficient. Subtle benefits, however, cannot be excluded because of the small sample size and the relatively short duration of the treatment.

摘要

韦尼克-科尔萨科夫综合征(WKD)在认知上是一种遗忘状态,由边缘系统中服务于情景记忆网络的策略性病变引起,且源于硫胺素缺乏。基于各种脑干和基底前脑核也受到影响的病理观察,神经化学缺陷与遗忘症的病理生理学有关。先前使用血清素能、去甲肾上腺素能和胆碱能药物的治疗尝试得出了有争议的结果。本研究的目的是评估胆碱酯酶抑制剂多奈哌齐对非酒精性WKD患者记忆、注意力和执行功能的影响。本单盲、安慰剂对照、单向交叉研究纳入了7名在绝食后患上WKD的患者。患者在头30天服用多奈哌齐,在接下来的30天服用安慰剂。在第0天、31天和61天进行神经心理学测试,以评估言语和视觉记忆、注意力和执行功能。所有患者均完成了研究的两个阶段。三次评估之间没有统计学上的显著差异,除了在回忆雷-奥斯特里赫复杂图形时,积极治疗与安慰剂阶段之间存在差异,该差异有利于安慰剂阶段。积极治疗没有显著的有利变化。在这项小型描述性研究中,用胆碱酯酶抑制剂多奈哌齐进行胆碱能治疗似乎并未给WKD患者带来明显的有益效果。这可能是因为介导通道和状态依赖性功能的通路在这种疾病中受损,且状态依赖性胆碱能传递的增强可能不足。然而,由于样本量小和治疗持续时间相对较短,不能排除有细微益处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验